THE MIRROR OF MEDIA

PepGen nabs $112.5m




PepGen Inc, a developer of oligonucleotide therapies for neuromuscular and neurologic ailments, has raised $112.5 million in financing.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *